VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
DOODY, RACHELLE
One or more keywords matched the following items that are connected to
DOODY, RACHELLE
Item Type
Name
Academic Article
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Academic Article
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
Academic Article
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Academic Article
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease.
Academic Article
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.
Concept
Antibodies, Monoclonal, Humanized
Academic Article
Gantenerumab reduces amyloid-? plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.
Academic Article
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Academic Article
Editorial: Consequences of the FDA Decision on Aducanumab for Patient Care and Research.
Academic Article
Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab.
Academic Article
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.
Academic Article
The Future of Anti-Amyloid Trials.
Academic Article
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.
Academic Article
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Academic Article
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Academic Article
Gantenerumab in Early Alzheimer's Disease. Reply.
Search Criteria
Antibodies Monoclonal Humanized